Exploring the triad: VPS35, neurogenesis, and neurodegenerative diseases
Zixiong Qiu,Xu Deng,Yuan Fu,Mei Jiang,Xiaojun Cui
DOI: https://doi.org/10.1111/jnc.16184
2024-07-20
Journal of Neurochemistry
Abstract:VPS35 deficiency or mutation can lead to dysfunction in autophagic–lysosomal pathways, abnormal protein accumulation, mitochondrial dysfunction, and impaired neuronal transmission, thereby promoting the onset of neurodegenerative diseases. Furthermore, VPS deficiency or mutation can result in defects in dendritic terminal differentiation, reduced neuronal proliferation, and increased inflammatory responses, inhibiting neurogenesis. The inhibition of neurogenesis exacerbates neurodegenerative diseases, which in turn suppress neurogenesis, creating a vicious cycle. A comprehensive understanding of the relationships between VPS35, neurogenesis, and neurodegenerative diseases is beneficial for elucidating the pathogenesis of neurodegenerative diseases. Targeting VPS35 in relation to neurogenesis holds promise for alleviating neurodegenerative diseases. Vacuolar protein sorting 35 (VPS35), a critical component of the retromer complex, plays a pivotal role in the pathogenesis of neurodegenerative diseases (NDs). It is involved in protein transmembrane sorting, facilitating the transport from endosomes to the trans‐Golgi network (TGN) and plasma membrane. Recent investigations have compellingly associated mutations in the VPS35 gene with neurodegenerative disorders such as Parkinson's and Alzheimer's disease. These genetic alterations are implicated in protein misfolding, disrupted autophagic processes, mitochondrial dysregulation, and synaptic impairment. Furthermore, VPS35 exerts a notable impact on neurogenesis by influencing neuronal functionality, protein conveyance, and synaptic performance. Dysregulation or mutation of VPS35 may escalate the progression of neurodegenerative conditions, underscoring its pivotal role in safeguarding neuronal integrity. This review comprehensively discusses the role of VPS35 and its functional impairments in NDs. Furthermore, we provide an overview of the impact of VPS35 on neurogenesis and further explore the intricate relationship between neurogenesis and NDs. These research advancements offer novel perspectives and valuable insights for identifying potential therapeutic targets in the treatment of NDs.
biochemistry & molecular biology,neurosciences